Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Acute Myeloblastic Leukaemia
Interventions
DRUG

ARA-C

DRUG

Idarubicin

DRUG

Leucomax

Trial Locations (24)

Unknown

Hospital General de Albacete, Albacete

Hospital Universitario, Alicante

Hospital Puerta del Mar, Cadiz

Hospital Ntra. Sra. del Rossell, Cartagena

Hospital General, Castellon

Hospital de Galdacano, Galdakao

Hospital Ciudad de Jaén, Jaén

Hospital Insular de las Palmas, Las Palmas de Gran Canaria

Hospital Xeral, Lugo

Hospital Clínico San Carlos, Madrid

Hospital Ramón y Cajal, Madrid

Hospital Universitario de Alcalá de Henares, Madrid

Hospital Virgen de la Victoria, Málaga

Hospital Morales Messeguer, Murcia

Hospital Virgen de la Arrixaca, Murcia

Hospital Central de Asturias, Oviedo

Clínica Universitaria de Pamplona, Pamplona

Hospital Montecelo, Pontevedra

Hospital Clínico Universitario, Salamanca

Hospital Arnau de Vilanova, Valencia

Hospital Clínico, Valencia

Hospital Dr. Pesset, Valencia

Hospital Clínico, Valladolid

Hospital Virgen de la Concha, Zamora

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT00464217 - Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years | Biotech Hunter | Biotech Hunter